Skip Navigation
Skip to contents

Clin Endosc : Clinical Endoscopy

OPEN ACCESS

Author index

Page Path
HOME > Browse articles > Author index
Search
Kimitoshi Kubo 2 Articles
Long-term follow-up of patients developing gastric mucosal lesions after initiating the potassium-competitive acid blocker vonoprazan
Kimitoshi Kubo, Noriko Kimura
Clin Endosc 2024;57(4):549-551.   Published online April 18, 2024
DOI: https://doi.org/10.5946/ce.2023.186
PDFPubReaderePub
  • 3,250 View
  • 241 Download
Close layer
Potassium-competitive acid blocker-associated gastric mucosal lesions
Kimitoshi Kubo, Noriko Kimura, Mototsugu Kato
Clin Endosc 2024;57(4):417-423.   Published online February 29, 2024
DOI: https://doi.org/10.5946/ce.2023.279
AbstractAbstract PDFPubReaderePub
Since the introduction of vonoprazan, a potassium-competitive acid blocker (P-CAB), it has been demonstrated to reversibly inhibit gastric acid secretion by engaging in potassium-competitive ionic binding to H+/K+-ATPase. In contrast, proton pump inhibitors (PPIs) achieve H+/K+-ATPase inhibition through covalent binding to cysteine residues of the proton pump. Reported cases have indicated an emerging trend of P-CAB-related gastropathies, similar to those associated with PPIs, as well as unique gastropathies specific to P-CAB use, such as the identification of web-like mucus. Pathologically, parietal cell profusions, which show a positively correlated with hypergastrinemia, have a higher incidence in P-CAB users compared to PPI users. Thus, this review aims to summarize the endoscopic and pathological findings reported to date concerning P-CAB-related gastric mucosal lesions. Additionally, it seeks to discuss the differences between the PPIs and P-CABs in terms of the formation and frequency of associated gastropathies. This review highlights the evident differences in the mechanism of action and potency of acid inhibition between P-CABs and PPIs, notably contributing to differences in the formation and frequency of associated gastropathies. It emphasizes the necessity to distinguish between P-CAB-related and PPI-related gastropathies in the clinical setting.

Citations

Citations to this article as recorded by  
  • Whitish gastric mucosa on upper gastrointestinal endoscopy
    Eun Jeong Gong, Chang Seok Bang
    Clinical Endoscopy.2024; 57(2): 277.     CrossRef
  • Vonoprazan-Associated Mucosal Redness: A Report of Two Cases
    Masaya Iwamuro, Yoshiyasu Kono, Takehiro Tanaka, Seiji Kawano, Nobumasa Ikeda
    Cureus.2024;[Epub]     CrossRef
  • 5,592 View
  • 498 Download
  • 1 Web of Science
  • 2 Crossref
Close layer

Clin Endosc : Clinical Endoscopy Twitter Facebook
Close layer
TOP